As the most widely used serum tumor markers, alpha-fetoprotein (AFP), carbohydrate antigen 19–9 (CA19–9) and carcinoembryonic antigen (CEA) have been in application since the 1970s [5, 6]. This evidence concerns the gene CEACAM5 and neoplasm.